ArticleTheranostics2021

c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.

Ya-Chu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.